Skip to main content
Clinical Trials/ISRCTN12049699
ISRCTN12049699CompletedNot Applicable

Randomized, single-blind, sham acupuncture-controlled trial of acupuncture treatment of breast cancer after chemotherapy in patients with cognitive impairment caused by 'disorder of qi and blood'

Beijing Hospital of Traditional Chinese Medicine (TCM)0 sites100 target enrollmentStarted: March 25, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • 1. Patients with breast cancer at the age of 25 to 55 years old
  • 2. Neuropsychological evidence of cognitive impairment
  • 3. In the 28 months after chemotherapy according to DSM-IV diagnosis of cognitive impairment
  • 4. According to the MoCA score < 26 points, determining with cognitive dysfunction
  • 5. There is a causal relationship between chemotherapy and cognitive impairment, and except for other diseases
  • 6. The type of traditional Chinese medicine is a disorder of qi and blood
  • 7. At least one field of cognitive dysfunction
  • 8. Diagnosis of dementia standard has not yet arrived
  • 9. Have signed informed consent

Exclusion Criteria

  • 1. Because of the depression, thyroid disease, traumatic brain injuries, drug or alcohol poisoning cause cognitive impairment
  • 2. Patients with severe aphasia, depression and mental illness
  • 3. Patients with severe heart, liver, lung, kidney damage caused by cognitive decline and hematopoietic system, endocrine system, severe primary disease
  • 4. Patients can affect the cognitive function of drugs

Investigators

Sponsor
Beijing Hospital of Traditional Chinese Medicine (TCM)

Similar Trials